Galectin Therapeutics Inc (GALT)
0.8952
-0.13
(-13.09%)
USD |
NASDAQ |
Dec 23, 15:06
Galectin Therapeutics Free Cash Flow: -33.68M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alaunos Therapeutics Inc | -11.76M |
| SELLAS Life Sciences Group Inc | -33.07M |
| Oragenics Inc | -7.682M |
| Anavex Life Sciences Corp | -30.00M |
| Phathom Pharmaceuticals Inc | -247.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.538M |
| Cash from Financing (Quarterly) | 10.00M |
| Free Cash Flow Per Share (Quarterly) | -0.1371 |
| Free Cash Flow Yield | -60.59% |